Remix Therapeutics Launches with $81 Million Financing to Develop Small Molecule Therapies Designed to Reprogram RNA Processing

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/37H1IiI
via IFTTT